| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-07 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-07 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-07 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-07 |
| mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-07 |